Rates of lobar atrophy in asymptomatic MAPT mutation carriers

Abstract Introduction The aim of this study was to investigate the rates of lobar atrophy in the asymptomatic microtubule‐associated protein tau (MAPT) mutation carriers. Methods MAPT mutation carriers (n = 14; 10 asymptomatic, 4 converters from asymptomatic to symptomatic) and noncarriers (n = 13)...

Full description

Bibliographic Details
Published in:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Main Authors:	Qin Chen, Bradley F. Boeve, Matthew Senjem, Nirubol Tosakulwong, Timothy G. Lesnick, Danielle Brushaber, Christina Dheel, Julie Fields, Leah Forsberg, Ralitza Gavrilova, Debra Gearhart, Jonathan Graff‐Radford, Neill R. Graff‐Radford, Clifford R. Jack Jr., David T. Jones, David S. Knopman, Walter K. Kremers, Maria Lapid, Rosa Rademakers, Jeremy Syrjanen, Adam L. Boxer, Howie Rosen, Zbigniew K. Wszolek, Kejal Kantarci, LEFFTDS Consortium
Format:	Article
Language:	English
Published:	Wiley 2019-01-01
Subjects:	Frontotemporal dementia Magnetic resonance image MAPT Asymptomatic Longitudinal
Online Access:	https://doi.org/10.1016/j.trci.2019.05.010

Similar Items

Knockdown of LncRNA MAPT-AS1 inhibites proliferation and migration and sensitizes cancer cells to paclitaxel by regulating MAPT expression in ER-negative breast cancers
by: Yiyuan Pan, et al.
Published: (2018-02-01)

A MAPT mutation in a regulatory element upstream of exon 10 causes frontotemporal dementia
by: Roneil Malkani, et al.
Published: (2006-05-01)

Hippocampal mitophagy alterations in MAPT-associated frontotemporal dementia with parkinsonism
by: Tyrique Richardson, et al.
Published: (2025-02-01)

Blood MAPT expression and methylation status in Alzheimer's disease
by: Hiroaki Mori, et al.
Published: (2022-12-01)

A comprehensive analysis of MAPT-related genetic risk in Alzheimer’s disease
by: Shitao Wang, et al.
Published: (2025-06-01)

<i>MAPT</i> Subhaplotypes in Different Progressive Supranuclear Palsy Phenotypes
by: Monica Gagliardi, et al.
Published: (2025-06-01)

Tau (MAPT) haplotypes in Jordan: new evidence on the Middle East as a melting-pot predating Neolithic migration
by: Almuthanna K. Alkaraki, et al.
Published: (2021-07-01)

Differential methylation of SNCA and MAPT genes associated with Parkinson’s disease in Mexican Mestizos
by: Ernesto G. Miranda-Morales, et al.
Published: (2025-07-01)

Astrocyte tau deposition in progressive supranuclear palsy is associated with dysregulation of MAPT transcription
by: Rosemary J. Jackson, et al.
Published: (2024-08-01)

Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue
by: Christina V. Tauber, et al.
Published: (2023-03-01)

An autopsied FTDP-17 case with MAPT IVS 10 + 14C > T mutation presenting with frontotemporal dementia
by: Ryohei Watanabe, et al.
Published: (2021-09-01)

Regulatory roles of eugenol in paraquat-altered SNCA/LZTS3/MAPT in the cerebellum of Wistar rats
by: Obinna Onwe Uchewa, et al.
Published: (2025-01-01)

Dissecting the Clinical Heterogeneity and Genotype-Phenotype Correlations of MAPT Mutations: A Systematic Review
by: Cristina Villa, et al.
Published: (2024-01-01)

What’s in a Gene? The Outstanding Diversity of <i>MAPT</i>
by: Daniel Ruiz-Gabarre, et al.
Published: (2022-03-01)

Functional MAPT haplotypes: Bridging the gap between genotype and neuropathology
by: Tara M. Caffrey, et al.
Published: (2007-07-01)

MAPT Mutations V337M and N297K Alter Organelle Trafficking in Frontotemporal Dementia Patient-Specific Motor Neurons
by: Christiane Hartmann, et al.
Published: (2024-03-01)

Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration
by: Lucia AA Giannini, et al.
Published: (2023-08-01)

Evaluation of a Frozen Micro-Agar Plates of MAPt Antibiotic Susceptibility Test for Enhanced Bioterror Preparedness
by: Shahar Rotem, et al.
Published: (2022-04-01)

Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies
by: Amy Easton, et al.
Published: (2022-09-01)

MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD
by: Lisanne Korn, et al.
Published: (2023-02-01)

Evidence for a Common Founder and Clinical Characteristics of Japanese Families with the MAPT R406W Mutation
by: Takeshi Ikeuchi, et al.
Published: (2011-09-01)

Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia
by: Paola Piscopo, et al.
Published: (2023-05-01)

Evolutionary perspective of Big tau structure: 4a exon variants of MAPT
by: Itzhak Fischer
Published: (2022-12-01)

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
by: Pascual Sánchez-Juan, et al.
Published: (2019-12-01)

MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy
by: Hadley W. Ressler, et al.
Published: (2024-08-01)

Preferential tau aggregation in von Economo neurons and fork cells in frontotemporal lobar degeneration with specific MAPT variants
by: Li-Chun Lin, et al.
Published: (2019-10-01)

Further validation of the association between MAPT haplotype-tagging polymorphisms and Alzheimer’s disease: neuropsychological tests, cerebrospinal fluid biomarkers, and APOE genotype
by: Mirjana Babić Leko, et al.
Published: (2024-09-01)

Imaging Biomarkers for Neurodegeneration in Presymptomatic Familial Frontotemporal Lobar Degeneration
by: Qin Chen, et al.
Published: (2020-02-01)

Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline
by: Frederic Sampedro, et al.
Published: (2018-05-01)

Clinical profile, atrophy and inheritance patterns of pathogenic MAPT gene mutations in Frontotemporal dementia detected using whole exome sequencing: a single-center first report from India
by: Subasree Ramakrishnan, et al.
Published: (2025-08-01)

A novel MAPT variant (E342K) as a cause of familial progressive supranuclear palsy
by: Hang Li, et al.
Published: (2024-04-01)

Generation and characterization of two induced pluripotent stem cell lines (ICGi052-A and ICGi052-B) from a patient with frontotemporal dementia with parkinsonism-17 associated with the pathological variant c.2013T>G in the MAPT gene
by: E. V. Grigor’eva, et al.
Published: (2024-11-01)

A heterozygous splicing variant IVS9-7A > T in intron 9 of the MAPT gene in a patient with right-temporal variant frontotemporal dementia with atypical 4 repeat tauopathy
by: Kohji Mori, et al.
Published: (2023-08-01)

Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration
by: Moumita Majumder, et al.
Published: (2024-06-01)

Changes in Oxidised Phospholipids in Response to Oxidative Stress in <i>Microtubule-Associated Protein Tau</i> (<i>MAPT</i>) Mutant Dopamine Neurons
by: Xanthe Bradford, et al.
Published: (2024-04-01)

Frontotemporal dementia parkinsonism: Clinical findings in a large Iranian family
by: Keivan Basiri, et al.
Published: (2015-01-01)

Single-cell RNA-seq reveals alterations in peripheral CX3CR1 and nonclassical monocytes in familial tauopathy
by: Daniel W. Sirkis, et al.
Published: (2023-07-01)

Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer
by: Cornelia Schroeder, et al.
Published: (2019-03-01)

Integrated analysis of the aging brain transcriptome and proteome in tauopathy
by: Carl Grant Mangleburg, et al.
Published: (2020-09-01)

The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort
by: Hannah D. Franklin, et al.
Published: (2021-07-01)